About us

About MediRama

Outline the company's identity as a "Pharma R&D Navigator" that connects
science to life by supporting pharmaceutical and biotech companies in new drug development

Science
Life

Mission & Vision

Emphasize MediRama’s mission to accelerate drug development through
innovative clinical and regulatory strategies, achieving regulatory
milestones faster and more efficiently.

Leadership Team

Our team of experts has extensive experience and expertise in new drug development
and clinical trials, providing customized consulting services tailored to your needs

CEO

Hanlim Moon, MD, PhD
  • CEO, CCS, Independent Consultant
  • Oncology Medical Director, Oncology R&D, GlaxoSmithKline
  • Senior Director, Oncology, International and Asia-Pacific, Sanofi-Aventis
  • Invited Scientist, NIAID, NIH, USA
  • Invited Scientist at National Cancer Center, Tokyo, Japan
  • Faculty Hemato-oncology, The Catholic University of Korea
  • Specialized field: Oncology R&D and Clinical Development

CCO

Hyunjung Roh

Chief Commercial Officer

Work experience

  • Broadhill Ventures, Vice President, Business Development and Investment
  • Mundipharma Korea, Sr. Commercial Excellence Manager
  • MSD Vietnam, Strategy & BD Manager
  • MSD Asia Pacific Region, AP Regional Marketing Lead for COZAAR / ZOCOR
  • MSD Korea & Asia Pacific Region, Business Development Manager
  • MSD Korea, Product Manager of Cardiovascular Disease Products
  • Specialized fields : Business Development, Product Planning, Strategic Planning and Commercial Execution

CCAO

Younghee Seo

Chief Corporate Affairs Officer

Work experience

  • HR Business Partner/Director, GlaxoSmithKline
  • Sr. Operation Manager, GlaxoSmithKline, Asia Regional office
  • Compensation Manager, GlaxoSmithKline, Pharma, Consumer and Ansan GMS
  • Specialized field: HR, Organizational Development, Finance

MD Professional

MD, MS

Inyoung Kim

Work experience

  • MD. MS., Internal Medicine, Rheumatology Board Certified
  • Clinical experiences in cancer, rare, autoimmune, and chronic metabolic diseases
  • Oncology clinical development and early-phase trial design
  • Development of targeted therapies, immuno-oncology agents, and targeted protein degrader
  • Medical monitoring and clinical safety management
  • Science and Technology Secretary Official/ National Hospital, Korea
  • Clinical fellow, Division of Rheumatology/Samsung Medical Center, Korea
  • Ph.D. student, Department of Clinical Research Design and Evaluation, SAIHST
  • Regulartory Affairs Professional Course

MD, MS

Eunkyo Joung

Work experience

  • MD. MS., Internal Medicine, Oncology Board Certified
  • Oncology clinical development and early-phase trial design
  • Development of cancer vaccines, bispecific antibodies, targeted therapies, and immuno-oncology agents
  • Medical monitoring and clinical safety management
  • Clinical Research Physician/Medical Monitor, Clinical Development Division, Pharma. Company
  • Clinical Director, Clinical Development Department, Biopharma. Company
  • Clinical Instructor, Division of Hematology-Oncology and Medical Oncology, University Hospital-Medical Center, Korea